248 related articles for article (PubMed ID: 26166433)
1. A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration.
Cao X; Kaneko T; Li JS; Liu AD; Voss C; Li SS
Nat Commun; 2015 Jul; 6():7721. PubMed ID: 26166433
[TBL] [Abstract][Full Text] [Related]
2. DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.
Joshi R; Qin L; Cao X; Zhong S; Voss C; Min W; Li SSC
J Biol Chem; 2020 Jan; 295(2):645-656. PubMed ID: 31806702
[TBL] [Abstract][Full Text] [Related]
3. Dynamic interplay of two molecular switches enabled by the MEK1/2-ERK1/2 and IL-6-STAT3 signaling axes controls epithelial cell migration in response to growth factors.
Qin L; Cao X; Kaneko T; Voss C; Liu X; Wang G; Li SS
J Biol Chem; 2021 Oct; 297(4):101161. PubMed ID: 34480897
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation.
Cao X; Voss C; Zhao B; Kaneko T; Li SS
Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1455-60. PubMed ID: 22307599
[TBL] [Abstract][Full Text] [Related]
5. Regulation by afadin of cyclical activation and inactivation of Rap1, Rac1, and RhoA small G proteins at leading edges of moving NIH3T3 cells.
Miyata M; Rikitake Y; Takahashi M; Nagamatsu Y; Yamauchi Y; Ogita H; Hirata K; Takai Y
J Biol Chem; 2009 Sep; 284(36):24595-609. PubMed ID: 19589776
[TBL] [Abstract][Full Text] [Related]
6. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.
Wang H; Quah SY; Dong JM; Manser E; Tang JP; Zeng Q
Cancer Res; 2007 Apr; 67(7):2922-6. PubMed ID: 17409395
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration.
Heering J; Erlmann P; Olayioye MA
Exp Cell Res; 2009 Sep; 315(15):2505-14. PubMed ID: 19482022
[TBL] [Abstract][Full Text] [Related]
8. Regulator of G-protein signalling 3 redirects prototypical Gi-coupled receptors from Rac1 to RhoA activation.
Vogt A; Lutz S; Rümenapp U; Han L; Jakobs KH; Schmidt M; Wieland T
Cell Signal; 2007 Jun; 19(6):1229-37. PubMed ID: 17300916
[TBL] [Abstract][Full Text] [Related]
9. Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.
Tripathi BK; Grant T; Qian X; Zhou M; Mertins P; Wang D; Papageorge AG; Tarasov SG; Hunter KW; Carr SA; Lowy DR
J Cell Biol; 2017 Dec; 216(12):4255-4270. PubMed ID: 29114068
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor activates the Rho GTPase-activating protein (GAP) Deleted in Liver Cancer 1 via focal adhesion kinase and protein phosphatase 2A.
Ravi A; Kaushik S; Ravichandran A; Pan CQ; Low BC
J Biol Chem; 2015 Feb; 290(7):4149-62. PubMed ID: 25525271
[TBL] [Abstract][Full Text] [Related]
11. Mechanism and role of localized activation of Rho-family GTPases in growth factor-stimulated fibroblasts and neuronal cells.
Kurokawa K; Nakamura T; Aoki K; Matsuda M
Biochem Soc Trans; 2005 Aug; 33(Pt 4):631-4. PubMed ID: 16042560
[TBL] [Abstract][Full Text] [Related]
12. Flavone inhibits migration through DLC1/RhoA pathway by decreasing ROS generation in breast cancer cells.
Zhu W; Ma L; Yang B; Zheng Z; Chai R; Liu T; Liu Z; Song T; Li F; Li G
In Vitro Cell Dev Biol Anim; 2016 May; 52(5):589-97. PubMed ID: 26935193
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-induced migration of human vascular smooth muscle cells requires coupling of the small GTPases RhoA and Rac1 to the Tyk2/PI3-K signalling pathway.
Kiian I; Tkachuk N; Haller H; Dumler I
Thromb Haemost; 2003 May; 89(5):904-14. PubMed ID: 12719789
[TBL] [Abstract][Full Text] [Related]
14. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced ARHGAP26 deficiency inhibits the proliferation and migration of human ductus arteriosus smooth muscle cell through activating RhoA-ROCK-PTEN pathway.
Li M; Ye L; Ye X; Wang S; Zhang H; Liu J; Hong H
J Cell Biochem; 2019 Jun; 120(6):10106-10117. PubMed ID: 30592323
[TBL] [Abstract][Full Text] [Related]
16. FKBP51 regulates cell motility and invasion via RhoA signaling.
Takaoka M; Ito S; Miki Y; Nakanishi A
Cancer Sci; 2017 Mar; 108(3):380-389. PubMed ID: 28032931
[TBL] [Abstract][Full Text] [Related]
17. srGAP1 regulates lamellipodial dynamics and cell migratory behavior by modulating Rac1 activity.
Yamazaki D; Itoh T; Miki H; Takenawa T
Mol Biol Cell; 2013 Nov; 24(21):3393-405. PubMed ID: 24006490
[TBL] [Abstract][Full Text] [Related]
18. FilGAP and its close relatives: a mediator of Rho-Rac antagonism that regulates cell morphology and migration.
Nakamura F
Biochem J; 2013 Jul; 453(1):17-25. PubMed ID: 23763313
[TBL] [Abstract][Full Text] [Related]
19. Role of RhoA in platelet-derived growth factor-BB-induced migration of rat hepatic stellate cells.
Li L; Li J; Wang JY; Yang CQ; Jia ML; Jiang W
Chin Med J (Engl); 2010 Sep; 123(18):2502-9. PubMed ID: 21034618
[TBL] [Abstract][Full Text] [Related]
20. Endogenous RhoG is rapidly activated after epidermal growth factor stimulation through multiple guanine-nucleotide exchange factors.
Samson T; Welch C; Monaghan-Benson E; Hahn KM; Burridge K
Mol Biol Cell; 2010 May; 21(9):1629-42. PubMed ID: 20237158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
